Financials
- Market Capitalization 920.8 M
- Employee 93
- Founded 2011
- CEO N/A
- Website www.annexonbio.com
- Headquarter Delaware, United States
- FIGI BBG007QVDFG2
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-3.75
売上高対価格比率
—
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 2524 | LBRX LB Pharmaceuticals Inc - Common Stock | 31.77 USD | -1.49% | -6.34% | +11.28% | +67.21% | 911.06 M USD | ||
| 2525 | ABUS Arbutus Biopharma Corporation - Common Stock | 4.61 USD | -1.28% | -8.71% | +7.21% | +42.72% | 910.65 M USD | ||
| 2535 | GERN Geron Corporation - Common Stock | 1.41 USD | -0.70% | -2.76% | +21.55% | +6.02% | 904.54 M USD | ||
| 2558 | TBPH Theravance Biopharma, Inc. - Ordinary Shares | 16.93 USD | +0.18% | -0.41% | +1.93% | +17.98% | 872.79 M USD |